Clincosm LogoSign in Get a demo

Uveitis

Showing 26 - 50 of 176
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Uveitis, Macular Edema Trial in Worldwide (Dexamethasone intravitreal implant 0.7 mg, Intravitreal Methotrexate 400 µg,

Completed
  • Uveitis
  • Macular Edema
  • Dexamethasone intravitreal implant 0.7 mg
  • +2 more
  • Los Angeles, California
  • +32 more
Mar 31, 2022

Objective Choroidal Thickness Measurements in Uveitis

Active, not recruiting
  • Uveitis
    • Wrocław, Poland
      Department of Ophthalmology
    Mar 27, 2022

    Uveitis Trial in Miami (Norflo Oro, Placebo for Norflo Oro)

    Completed
    Has Results
    • Uveitis
    • Norflo Oro
    • Placebo for Norflo Oro
    • Miami, Florida
      Bascom Palmer Eye Institute
    Mar 25, 2022

    Uveitis, JIA Trial in Australia, United Kingdom, United States (Adalimumab, Placebo)

    Recruiting
    • Uveitis
    • JIA
    • Adalimumab
    • Placebo
    • Sacramento, California
    • +24 more
    Mar 9, 2022

    Lyon Uveitis Study

    Recruiting
    • Uveitis
    • No specific intervention. Collection of clinical data
    • Lyon, France
      Department of Internal Medicine, Croix-Rousse Hospital, Hospices
    Mar 18, 2022

    Uveitis Trial in Spain (Methotrexate, Adalimumab, Adalimumab+Methotrexate)

    Recruiting
    • Uveitis
    • A Coruña, Spain
    • +13 more
    Mar 15, 2022

    Uveitis, Cystoid Macular Edema Trial in Winston-Salem (Pegaptanib)

    Completed
    Has Results
    • Uveitis
    • Cystoid Macular Edema
    • Winston-Salem, North Carolina
      Wake Forest University Eye Center
    Mar 7, 2022

    Hereditary Autoinflammatory Diseases, Schnitzler Syndrome, Behcet Syndrome Trial in Worldwide (No intervention is foreseen by

    Recruiting
    • Hereditary Autoinflammatory Diseases
    • +7 more
    • No intervention is foreseen by the protocol.
    • Bethesda, Maryland
    • +99 more
    Jan 6, 2022

    Uveitis Trial (QLETLI)

    Not yet recruiting
    • Uveitis
    • (no location specified)
    Dec 18, 2021

    Uveitis Trial in Guangzhou (Adalimumab plus Methotrexate)

    Recruiting
    • Uveitis
    • Adalimumab plus Methotrexate
    • Guangzhou, Guangdong, China
      Zhongshan Ophthalmic Center, Sun Yat-sen University
    Dec 26, 2021

    Uveitis, Adalimumab Trial in Guangzhou (reduction or discontinuation of Adalimumab)

    Recruiting
    • Uveitis
    • Adalimumab
    • reduction or discontinuation of Adalimumab
    • Guangzhou, Guangdong, China
      Zhongshan Ophthalmic Center, Sun Yat-sen University
    Dec 9, 2021

    Phenomics in Autoimmune and Inflammatory Diseases

    Recruiting
    • Healthy Volunteer
    • +12 more
    • 1: AID groups
    • 2: Control groups
    • Paris, France
    • +1 more
    Dec 10, 2021

    High Resolution Optical Coherence Tomography

    Not yet recruiting
    • Retinal Disease
    • +15 more
    • High-resolution optical coherence tomography (High-Res-OCT)
    • Standard spectral domain OCT (SD-OCT)
    • Bern 3010, Bern, Switzerland
      Department of Ophthalmology, Bern University Hospital, Bern, 301
    Nov 17, 2021

    Mutation Detection for VRL

    Enrolling by invitation
    • Vitreoretinal Lymphoma
    • Uveitis
    • mutation test
    • Guangzhou, Guangdong, China
      Zhongshan Ophthalmic Center, Sun Yat-sen University
    Nov 12, 2021

    Uveitis Trial (Adalimumab plus different doses of oral glucocorticosteroid)

    Not yet recruiting
    • Uveitis
    • Adalimumab plus different doses of oral glucocorticosteroid
    • (no location specified)
    Nov 1, 2021

    Uveitis, Infliximab Trial (infliximab)

    Active, not recruiting
    • Uveitis
    • Infliximab
    • (no location specified)
    Oct 28, 2021

    Paediatric Uveitis Population Reported by Patients and Parents

    Completed
    • Uveitis
      • Manchester, United Kingdom
        Manchester Royal Eye Hospital
      Aug 10, 2021

      Optical Coherence Tomography (OCT) in Uveitis

      Recruiting
      • Uveitis
        • Portland, Oregon
          Oregon Health & Science University
        Jul 13, 2021

        Uveitis Trial (adalimumab)

        Completed
        Has Results
        • Uveitis
        • (no location specified)
        Jul 8, 2021

        Uveitis Trial (Adalimumab, Prednisone, Placebo)

        Completed
        Has Results
        • Uveitis
        • (no location specified)
        Jul 2, 2021

        Uveitis Trial (Adalimumab, Prednisone, Placebo)

        Completed
        Has Results
        • Uveitis
        • Adalimumab
        • +2 more
        • (no location specified)
        Jul 2, 2021

        Autoimmune Diseases, IBD, Crohn Disease (CD) Trial in Aabenraa, Herlev, Odense (Primary exposure variable, Other (exploratory)

        Completed
        • Autoimmune Diseases
        • +9 more
        • Primary exposure variable
        • Other (exploratory) exposure variables
        • Aabenraa, Denmark
        • +2 more
        Jun 30, 2021

        Uveitis, Uveitis, Posterior, Uveitis, Anterior Trial in United States (4 mg CLS-TA Suprachoriodal Injection)

        Completed
        Has Results
        • Uveitis
        • +4 more
        • 4 mg CLS-TA Suprachoriodal Injection
        • Phoenix, Arizona
        • +9 more
        Jun 18, 2021

        Non-infectious Uveitis Who Participated in CLS1001-301

        Completed
        Has Results
        • Uveitis
        • +4 more
        • 4 mg CLS-TA Suprachoriodal Injection
        • Sham procedure
        • Phoenix, Arizona
        • +15 more
        May 13, 2021

        Uveitis, Uveitis, Posterior, Uveitis, Anterior Trial in India, Israel, United States (4mg CLS-TA Suprachoriodal Injection, Sham

        Completed
        Has Results
        • Uveitis
        • +4 more
        • 4mg CLS-TA Suprachoriodal Injection
        • Sham Procedure
        • Phoenix, Arizona
        • +63 more
        May 4, 2021